Loading insider details...
Latest Form 4 (Aug 24, 2026): Exercise/Conversion of 2,827 RCUS shares, $43.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 24, 2026 | Arcus Biosciences, Inc. (RCUS) | Exercise/Conversion | 2,827 | $43.6K |
| Jun 1, 2026 | Arcus Biosciences, Inc. (RCUS) | Sale | 2,562 | $66.0K |
| Jan 27, 2026 | Arcus Biosciences, Inc. (RCUS) | Grant/Award | 21,050 | n/a |
| Dec 18, 2025 | Arcus Biosciences, Inc. (RCUS) | Sale | 2,376 | $52.0K |
| Dec 1, 2025 | Arcus Biosciences, Inc. (RCUS) | Exercise/Conversion | 1,900 | $25.3K |
| Sep 30, 2025 | Arcus Biosciences, Inc. (RCUS) | Sale | 2,831 | $36.8K |
| Sep 5, 2025 | Arcus Biosciences, Inc. (RCUS) | Sale | 1,579 | $18.8K |
| Jan 27, 2025 | Arcus Biosciences, Inc. (RCUS) | Grant/Award | 17,100 | n/a |
| Dec 20, 2024 | Arcus Biosciences, Inc. (RCUS) | Disposition to Issuer | 3,007 | $45.6K |
| Dec 18, 2024 | Arcus Biosciences, Inc. (RCUS) | Tax Withholding | 2,969 | $47.7K |